These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 11251173)
1. Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors. van der Looij M; Papp J; Sztán M; Pulay T; Elfadil I; Besznyak I; Tóth J; Devilee P; Oláh E Int J Oncol; 2001 Apr; 18(4):775-80. PubMed ID: 11251173 [TBL] [Abstract][Full Text] [Related]
2. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer. Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754 [TBL] [Abstract][Full Text] [Related]
3. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient. Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424 [TBL] [Abstract][Full Text] [Related]
4. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors. Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267 [TBL] [Abstract][Full Text] [Related]
5. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836 [TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the BRCA1 gene in ovarian cancers. Takahashi H; Behbakht K; McGovern PE; Chiu HC; Couch FJ; Weber BL; Friedman LS; King MC; Furusato M; LiVolsi VA Cancer Res; 1995 Jul; 55(14):2998-3002. PubMed ID: 7606717 [TBL] [Abstract][Full Text] [Related]
7. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Tirkkonen M; Johannsson O; Agnarsson BA; Olsson H; Ingvarsson S; Karhu R; Tanner M; Isola J; Barkardottir RB; Borg A; Kallioniemi OP Cancer Res; 1997 Apr; 57(7):1222-7. PubMed ID: 9102202 [TBL] [Abstract][Full Text] [Related]
8. Mutations of the BRCA2 gene in ovarian carcinomas. Takahashi H; Chiu HC; Bandera CA; Behbakht K; Liu PC; Couch FJ; Weber BL; LiVolsi VA; Furusato M; Rebane BA; Cardonick A; Benjamin I; Morgan MA; King SA; Mikuta JJ; Rubin SC; Boyd J Cancer Res; 1996 Jun; 56(12):2738-41. PubMed ID: 8665505 [TBL] [Abstract][Full Text] [Related]
9. Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group. Pharoah PD; Easton DF; Stockton DL; Gayther S; Ponder BA Cancer Res; 1999 Feb; 59(4):868-71. PubMed ID: 10029077 [TBL] [Abstract][Full Text] [Related]
10. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1. Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ; J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670 [TBL] [Abstract][Full Text] [Related]
11. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer. Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013 [TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer. Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281 [TBL] [Abstract][Full Text] [Related]
13. The Brca1 and Brca2 proteins and tumor pathogenesis. Ingvarsson S Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564 [TBL] [Abstract][Full Text] [Related]
14. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations. Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400 [TBL] [Abstract][Full Text] [Related]
15. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786 [TBL] [Abstract][Full Text] [Related]
16. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2. Ramus SJ; Friedman LS; Gayther SA; Ponder BA; Bobrow L; van der Looji M; Papp J; Olah E Nat Genet; 1997 Jan; 15(1):14-5. PubMed ID: 8988162 [No Abstract] [Full Text] [Related]
17. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Birgisdottir V; Stefansson OA; Bodvarsdottir SK; Hilmarsdottir H; Jonasson JG; Eyfjord JE Breast Cancer Res; 2006; 8(4):R38. PubMed ID: 16846527 [TBL] [Abstract][Full Text] [Related]
18. Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer. Hamann U; Herbold C; Costa S; Solomayer EF; Kaufmann M; Bastert G; Ulmer HU; Frenzel H; Komitowski D Cancer Res; 1996 May; 56(9):1988-90. PubMed ID: 8616837 [TBL] [Abstract][Full Text] [Related]
19. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895 [TBL] [Abstract][Full Text] [Related]
20. Searching for microsatellite mutations in coding regions in lung, breast, ovarian and colorectal cancers. Forgacs E; Wren JD; Kamibayashi C; Kondo M; Xu XL; Markowitz S; Tomlinson GE; Muller CY; Gazdar AF; Garner HR; Minna JD Oncogene; 2001 Feb; 20(8):1005-9. PubMed ID: 11314036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]